Celyad Oncology SA (EBR:CYAD)
Belgium
· Delayed Price · Currency is EUR 0.338
-0.027 (-7.40%)
Mar 9, 2026, 3:57 PM CET
Celyad Oncology Revenue
Celyad Oncology had revenue of 14.00K EUR in the half year ending June 30, 2025, a decrease of -68.18%. This brings the company's revenue in the last twelve months to 186.00K, up 158.33% year-over-year. In the year 2024, Celyad Oncology had annual revenue of 186.00K with 82.35% growth.
Revenue
186.00K
Revenue Growth
+158.33%
P/S Ratio
87.84
Revenue / Employee
10.33K
Employees
19
Market Cap
16.34M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| European Medical Solutions | 49.47M |
| BioSenic | -2.39M |
| Hyloris Pharmaceuticals | 8.46M |
| Onward Medical | 2.72M |
| Oxurion NV | 2.00K |
| Financière de Tubize | 13.26K |
| argenx SE | 3.62B |
| UCB SA | 7.74B |